Fedorova N V, Glozman Zh M, Saltykova N M
Ter Arkh. 1995;67(10):75-7.
18 patients with early parkinsonism presenting in different clinical forms have undergone 3-month treatment with umex (10 mg/day). The response was evaluated in accordance with unified scale assessing the condition, motor tests, personal and reactive anxiety. Umex brought a significant improvement of motor activity, prolonged the effect of a single dose of DOPA-containing medication, reduced anxiety. Side effects were insignificant.
18例表现为不同临床形式的早期帕金森病患者接受了3个月的优麦克斯（10毫克/天）治疗。根据评估病情的统一量表、运动测试、个人焦虑和反应性焦虑对疗效进行了评估。优麦克斯显著改善了运动活性，延长了单剂量含多巴药物的作用时间，减轻了焦虑。副作用不明显。
